Literature DB >> 7857740

Increased circulating cytokines in patients with myocarditis and cardiomyopathy.

A Matsumori1, T Yamada, H Suzuki, Y Matoba, S Sasayama.   

Abstract

OBJECTIVES: To elucidate the potential role of cytokines in the pathogenesis of cardiomyopathy and myocarditis.
BACKGROUND: Experimental studies show that certain cytokines depress myocardial contractility and that tumour necrosis factor-alpha plays an important part in the pathogenesis of myocardial injury in animal models of viral and autoimmune myocarditis.
METHODS: Plasma interleukin 1-alpha, interleukin 1-beta, interleukin-2, interleukin-6, tumour necrosis factor-alpha, tumour necrosis factor-beta, granulocyte-macrophage colony stimulating factor, granulocyte colony stimulating factor, macrophage colony stimulating factor, interferon-alpha and interferon-gamma were measured in 13 patients with acute myocarditis, 23 patients with dilated cardiomyopathy, 51 patients with hypertrophic cardiomyopathy, nine patients with acute myocardial infarction, 18 patients with angina pectoris, 12 patients with essential hypertension and 17 healthy controls.
RESULTS: Increased concentrations of cytokines were not detected in the controls. In patients with acute myocarditis, interleukin 1-alpha was detected in 23% (mean (SD) 25 (11) pg/ml), tumour necrosis factor-alpha in 46% (61 (31) pg/ml), and macrophage colony stimulating factor was 2.5 (1.8) ng/ml (normal 1.9 (0.4)). In patients with dilated cardiomyopathy, tumour necrosis factor-alpha was detected in 35% (402 (555) pg/ml). In patients with hypertrophic cardiomyopathy, interleukin-2 was detectable in 14% (2318 (4738) pg/ml) and tumour necrosis factor-alpha ws detected in 20% (992 (1517) pg/ml). The concentration of macrophage colony stimulating factor was raised in patients with acute myocardial infarction. Granulocyte colony stimulating factor was often increased in myocarditis, cardiomyopathies, acute myocardial infarction, and angina pectoris--suggesting activation of macrophages and/or endothelial cells--but this increase was not specific to these diseases. Increased concentrations of cytokines were not found in patients with essential hypertension.
CONCLUSION: These results suggest that cytokines may play a part in the pathogenesis of myocardial injury in myocarditis and cardiomyopathies and that further studies to explore the potential pathogenetic role of cytokines in myocardial diseases may be warranted.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7857740      PMCID: PMC1025643          DOI: 10.1136/hrt.72.6.561

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  35 in total

1.  HL-A and hypertrophic cardiomyopathy.

Authors:  A Matsumori; K Hirose; A Wakabayashi; C Kawai; N Nabeya; T Sakurami; K Tsuji
Journal:  Am Heart J       Date:  1979-04       Impact factor: 4.749

Review 2.  The challenge of cardiomyopathy.

Authors:  W H Abelmann; B H Lorell
Journal:  J Am Coll Cardiol       Date:  1989-05       Impact factor: 24.094

3.  Myocarditis. A histopathologic definition and classification.

Authors:  H T Aretz; M E Billingham; W D Edwards; S M Factor; J T Fallon; J J Fenoglio; E G Olsen; F J Schoen
Journal:  Am J Cardiovasc Pathol       Date:  1987-01

4.  Deficient natural killer cell activity in patients with idiopathic dilated cardiomyopathy.

Authors:  J L Anderson; J F Carlquist; E H Hammond
Journal:  Lancet       Date:  1982-11-20       Impact factor: 79.321

5.  Reduced suppressor cell activity in congestive cardiomyopathy and in myocarditis.

Authors:  R Eckstein; W Mempel; H D Bolte
Journal:  Circulation       Date:  1982-06       Impact factor: 29.690

6.  T-cell growth factor gene: lack of expression in human T-cell leukemia-lymphoma virus-infected cells.

Authors:  S K Arya; F Wong-Staal; R C Gallo
Journal:  Science       Date:  1984-03-09       Impact factor: 47.728

Review 7.  Myocarditis and dilated cardiomyopathy.

Authors:  C Kawai; A Matsumori; H Fujiwara
Journal:  Annu Rev Med       Date:  1987       Impact factor: 13.739

8.  Therapeutic effect of anti-tumor necrosis factor-alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus.

Authors:  T Yamada; A Matsumori; S Sasayama
Journal:  Circulation       Date:  1994-02       Impact factor: 29.690

9.  Recombinant human TNF alpha stimulates production of granulocyte colony-stimulating factor.

Authors:  H P Koeffler; J Gasson; J Ranyard; L Souza; M Shepard; R Munker
Journal:  Blood       Date:  1987-07       Impact factor: 22.113

10.  Cachectin/tumor necrosis factor mediates changes of skeletal muscle plasma membrane potential.

Authors:  K J Tracey; S F Lowry; B Beutler; A Cerami; J D Albert; G T Shires
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

View more
  86 in total

Review 1.  Cytokines and their receptors in cardiovascular diseases--role of gp130 signalling pathway in cardiac myocyte growth and maintenance.

Authors:  K Yamauchi-Takihara; T Kishimoto
Journal:  Int J Exp Pathol       Date:  2000-02       Impact factor: 1.925

Review 2.  Activation of cytokines as a mechanism of disease progression in heart failure.

Authors:  B Bozkurt
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

Review 3.  Optimising outcomes in end-stage heart failure: differences in therapeutic responses between diverse ethnic groups.

Authors:  Shigetake Sasayama
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

Review 4.  Scaffolds, levers, rods and springs: diverse cellular functions of long coiled-coil proteins.

Authors:  A Rose; I Meier
Journal:  Cell Mol Life Sci       Date:  2004-08       Impact factor: 9.261

5.  Inflammatory mediators in chronic heart failure: an overview.

Authors:  Stefan D Anker; Stephan von Haehling
Journal:  Heart       Date:  2004-04       Impact factor: 5.994

Review 6.  [Cytokines and heart diseases. Attempt at an update].

Authors:  K Werdan
Journal:  Med Klin (Munich)       Date:  1997-07-15

Review 7.  Toll-like receptors: new players in myocardial ischemia/reperfusion injury.

Authors:  Tuanzhu Ha; Li Liu; Jim Kelley; Race Kao; David Williams; Chuanfu Li
Journal:  Antioxid Redox Signal       Date:  2011-04-08       Impact factor: 8.401

8.  Myocardial Inflammation, Measured Using 18-Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography, Is Associated With Disease Activity in Rheumatoid Arthritis.

Authors:  Isabelle Amigues; Aylin Tugcu; Cesare Russo; Jon T Giles; Rachelle Morgenstein; Afshin Zartoshti; Christian Schulze; Raul Flores; Sabahat Bokhari; Joan M Bathon
Journal:  Arthritis Rheumatol       Date:  2019-02-28       Impact factor: 10.995

9.  Systemic inflammation is associated with myocardial fibrosis, diastolic dysfunction, and cardiac hypertrophy in patients with hypertrophic cardiomyopathy.

Authors:  Lu Fang; Andris H Ellims; Anna L Beale; Andrew J Taylor; Andrew Murphy; Anthony M Dart
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

10.  The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy.

Authors:  Junichi Sadoshima; Olivier Montagne; Qian Wang; Guiping Yang; Jill Warden; Jing Liu; Gen Takagi; Vijaya Karoor; Chull Hong; Gary L Johnson; Dorothy E Vatner; Stephen F Vatner
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.